Boston Trust Walden Corp Trims Position in Chemed Corporation $CHE

Key Points

• Boston Trust Walden Corp cut its Chemed stake by 7.3% in the first quarter, selling 16,044 shares and ending with 205,197 shares valued at about $77.5 million.
• Chemed reported stronger-than-expected quarterly earnings, posting EPS of $5.65 versus the $5.30 consensus, while revenue came in slightly below estimates at $657.5 million.
• Analyst sentiment remains cautious: the stock currently carries an average Hold rating with a mean target price of $501.50, even as Royal Bank of Canada nudged its price target up to $436.

Boston Trust Walden Corp lessened its holdings in shares of Chemed Corporation (NYSE:CHE - Free Report) by 7.3% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 205,197 shares of the company's stock after selling 16,044 shares during the quarter. Boston Trust Walden Corp owned approximately 1.40% of Chemed worth $77,511,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CHE. Monetary Solutions Ltd purchased a new position in Chemed during the 4th quarter valued at $25,000. Los Angeles Capital Management LLC purchased a new position in shares of Chemed during the fourth quarter valued at about $26,000. BOK Financial Private Wealth Inc. purchased a new position in shares of Chemed during the fourth quarter valued at about $27,000. Global Retirement Partners LLC raised its stake in Chemed by 200.0% in the fourth quarter. Global Retirement Partners LLC now owns 87 shares of the company's stock worth $37,000 after buying an additional 58 shares in the last quarter. Finally, Rothschild Investment LLC lifted its holdings in Chemed by 800.0% in the fourth quarter. Rothschild Investment LLC now owns 108 shares of the company's stock worth $46,000 after buying an additional 96 shares during the period. Hedge funds and other institutional investors own 95.85% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on CHE shares. Zacks Research upgraded Chemed from a "strong sell" rating to a "hold" rating in a report on Monday, April 27th. Wall Street Zen lowered Chemed from a "buy" rating to a "hold" rating in a research report on Monday, June 8th. Weiss Ratings raised Chemed from a "sell (d+)" rating to a "hold (c-)" rating in a research note on Wednesday, April 29th. Finally, Royal Bank Of Canada raised their price objective on Chemed from $422.00 to $436.00 and gave the company a "sector perform" rating in a research report on Monday, April 27th. Two research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company's stock. According to MarketBeat, Chemed presently has an average rating of "Hold" and an average target price of $501.50.

Chemed Price Performance

Shares of NYSE CHE opened at $489.54 on Friday. Chemed Corporation has a fifty-two week low of $365.20 and a fifty-two week high of $492.30. The company has a 50 day simple moving average of $433.81 and a two-hundred day simple moving average of $426.39. The company has a market capitalization of $6.50 billion, a price-to-earnings ratio of 26.68, a P/E/G ratio of 1.80 and a beta of 0.52. The company has a debt-to-equity ratio of 0.11, a quick ratio of 0.83 and a current ratio of 0.85.

Chemed (NYSE:CHE - Get Free Report) last issued its quarterly earnings results on Thursday, April 23rd. The company reported $5.65 EPS for the quarter, topping analysts' consensus estimates of $5.30 by $0.35. The firm had revenue of $657.51 million for the quarter, compared to analysts' expectations of $659.22 million. Chemed had a return on equity of 27.18% and a net margin of 10.23%.The business's revenue for the quarter was up 1.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $5.63 EPS. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. Analysts expect that Chemed Corporation will post 22.3 EPS for the current fiscal year.

Chemed Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 16th. Shareholders of record on Thursday, May 28th were issued a $0.60 dividend. This represents a $2.40 annualized dividend and a yield of 0.5%. The ex-dividend date of this dividend was Thursday, May 28th. Chemed's payout ratio is 13.08%.

Insiders Place Their Bets

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction dated Friday, May 1st. The stock was sold at an average price of $421.13, for a total value of $842,260.00. Following the completion of the transaction, the chief executive officer owned 90,219 shares of the company's stock, valued at $37,993,927.47. The trade was a 2.17% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Andrea R. Lindell sold 1,347 shares of the company's stock in a transaction dated Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total transaction of $602,553.51. Following the completion of the transaction, the director owned 4,578 shares in the company, valued at approximately $2,047,876.74. The trade was a 22.73% decrease in their position. The disclosure for this sale is available in the SEC filing. Corporate insiders own 3.33% of the company's stock.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corporation (NYSE:CHE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.